Organometallics
Article
CDCl3, 1H and 13C{1H} NMR chemical shifts are reported relative to
CHCl3 at 7.26 and 77.16 ppm, respectively; in CD2Cl2, 1H and 13C{1H}
NMR chemical shifts are reported relative to CH2Cl2 at 5.32 and 54.0
(s, 1H, NH), 4.13 (t, J = 5.4, 1H, CH(PPh2)2), 2.47 (sept, J = 6.9, 2H,
CH, obscured by H of 2c), 2.03 (td, J = 10.8, J = 5.4, 2H,
CH2CH(PPh2)2), 0.83 (d, J = 6.9, 12H, CH3), 0.72 (d, J = 6.9, 12H,
CH3). 13C{1H) NMR (126 MHz, CDCl3): 2c, δ 170.5 (t, J = 3.3, CO),
146.3 (s, o-Ar) 136.5 (m, PPh2), 134.5 (app t, J = 11.0, PPh2H), 134.0
(app t, J = 10.5, PPh2H), 131.0 (i-Ar), 129.1 (PPh2H), 128.9 (PPh2H),
128.4 (m, p-ArH/PPh2H), 123.5 (s, m-ArH), 35.9 (t, J = 9.8,
CH2CH(PPh2)2), 28.5 (s, CH(CH3)2), 25.8 (t, J = 24.3, CH2CH-
(PPh2)2), 23.7 (s, CH3); 2c′, 146.9 (s, o-Ar), 134.5 (app t, J = 11.1,
PPh2H), 134.4 (app t, J = 10.7, PPh2H), 131.0 (i-Ar), 129.0 (PPh2H),
128.7 (PPh2H), 128.2 (m, p-ArH/PPh2H), 123.8 (s, m-ArH), 28.3 (s,
CH(CH3)2), 25.0 (s, CH3), 14.3 (s, CH3). 31P{1H} NMR (202 MHz,
CDCl3): δ −3.2 (2c′), −3.4 (2c); mp (°C) 134−137. FTIR-ATR: ν
(cm−1): 3285 (NH), 1683 (CO). HRMS (ESI−): calcd for
C40H42NO3P2− [M − HCOO−] 646.2640; found: 646.2659.
[Ti(NMe2)2(O,N-2a)2] 3a. A J-Young NMR tube was charged with
2a (25 mg, 0.046 mmol), and then C6D6 (0.5 mL) was added without
stirring. Ti(NMe2)4 (5.3 μL, 0.023 mmol) was added to the solution,
which turned orange, and they were mixed at RT and left for 1 h.
Compound 3a was formed together with 3a′ in a 7:1 ratio. The mixture
was dried in vacuo, and n-hexane was added (2 mL) at 0 °C followed by
cannula filtration to obtain 3a as an oil (76% spectroscopic yield) which
was analyzed in situ. 1H NMR (500 MHz, C6D6): δ 7.74−7.67 (m, 8H,
PPh2), 7.49−7.43 (m, 8H, PPh2), 7.11−6.93 (m, 28H, PPh2/m-ArH),
6.87 (t, J = 7.5, 2H, p-ArH) 6.57 (d, J = 7.4, 4H, o-ArH), 4.41 (t, J = 6.3,
2H, CH2CH(PPh2)2), 3.41 (s, 12H, NMe2), 2.72 (td, J = 11.1, J = 6.3,
4H, CH2CH(PPh2)2). 13C{1H} NMR (126 MHz, C6D6): δ 180.5 (m,
CO), 145.6 (s, i-Ar), 137.4 (app t, J = 5.7, PPh2), 136.9 (app t, J = 6.2,
PPh2), 134.2 (app t, J = 10.9, PPh2), 134.1 (app t, J = 10.7, PPh2), 128.5
(PPh2), 128.3 (app t, J = 3.6, PPh2), 128.2 (app t, J = 4.6, PPh2), 128.2
(s, m-ArH). 128.1 (app t, J = 3.5, PPh2), 124.5 (o-ArH), 123.9 (p-ArH),
46.5 (NMe2), 33.0 (t, J = 11.6, CH2CH(PPh2)2), 26.2 (t, J = 29.0,
CH2CH(PPh2)2). 31P{1H} NMR (202 MHz, C6D6): δ −4.5; D = 4.66
× 10−10 m2 s−1 (3.26 × 10−11 m2 s−1).
[Ti(NMe2)3(O,N-2a)] 3a′. A Schlenk flask was charged with 2a
(11.9 mg, 0.023 mmol), and then C6D6 (0.5 mL) was added without
stirring. Ti(NMe2)4 (5.3 μL, 0.023 mmol) was added to the solution,
which turned light orange, and they were stirred slowly at RT and left
for 1 h then analyzed in situ by NMR spectroscopy. The ratio between
3a:3a′ was of 1:6.5, and attempts at separation were unsuccessful. 1H
NMR (300 MHz, C6D6): δ 7.72 (m, 6H, PPh2), 7.48 (m, 4H), 7.01 (m,
22H), 6.91−6.82 (m, 1H), 6.61−6.51 (m, 3a), 4.53 (t, J = 6.0, 1H,
CH2CH(PPh2)2), 4.41 (t, J = 6.3, 3a), 3.40 (s, 2H, 3a), 3.26 (s, 18H,
NMe2), 3.11 (s, 10H), 2.71 (td, J = 10.5, 6.1, 2H, CH2CH(PPh2)2),
2.20 (d, J = 6.4, 12H, HNMe2). 13C{1H} NMR (75 MHz, C6D6): δ
182.1, 145.7, 137.6, 137.2, 137.1, 134.9, 134.7, 134.6, 134.5, 134.4,
134.3, 134.2, 128.9, 128.8, 128.5, 124.6, 124.1, 46.8, 45.7, 45.0, 44.2,
44.1, 39.0, 32.7 (t, J = 10.9, CH2CH(PPh2)2), 26.61 (t, J = 27.5,
CH2CH(PPh2)2). 31P{1H} NMR (122 MHz, C6D6): δ −3.9, −39.8
(traces HPPh2 from the pro-ligand synthesis). D = 6.46 × 10−10 m2 s−1
(1.677 × 10−10 m2 s−1).
[Ti(NMe2)2(O,N-2b)2] 3b. A Schlenk flask was charged with 2b
(245.5 mg, 0.45 mmol), and then C6D6 (0.5 mL) was added without
stirring. Ti(NMe2)4 (34.6 μL, 0.15 mmol) was added to the solution,
which turned orange, and they were stirred slowly at RT for 1 h. After
this time residual benzene and HPPh2 were removed from the crude
product by dissolving the solid in hot hexane (5 mL), cooling the
solution to −78 °C, and then filtering through a cannula. The resulting
solid was washed with a further 2 mL of cold hexane. The compound
was dried in vacuo and used without further purification. The
compound was isolated as an orange powder in 81% yield (142 mg,
0.12 mmol), with 1H NMR showing 0.5 equiv of n-hexane.
Crystallization attempts to obtain single crystals were unsuccessful.
1H{31P} NMR (500 MHz, C6D6): δ 7.66 (br s, 8H, PPh2), 7.21 (br s,
8H, PPh2), 7.11−6.93 (m, 30H, PPh2/Ar/H), 4.15 (t, J = 7.0, 2H,
CH2CH(PPh2)2), 3.48 (s, 12H, NMe2), 2.49 (d, J = 7.0, 4H,
CH2CH(PPh2)2), 2.20 (s, 12H, ArMe). 13C{1H} NMR (126 MHz,
C6D6): δ 181.7 (CO), 143.7 (o-ArMe), 137.6−137.5 (m, PPh2),
137.4−137.3 (m, PPh2), 134.8−134.6 (m, PPh2), 134.2−134.0 (m,
PPh2), 133.3 (m-ArH), 129.0 (PPh2), 128.8 (app t, J = 3.6, PPh2), 128.5
1
ppm, respectively For the assignment of the H and 13C{1H} NMR
spectra 2D NMR (COSY, HSQC, HMBC) experiments were also
performed. Coupling constants (J) are reported in hertz (Hz).
Multiplicities are indicated by br s (broad singlet), s (singlet), d
(doublet), t (triplet), q (quartet), and m (multiplet). Simulation NMR
spectra were performed by using gNMR 5.0. Air sensitive mass
spectrometry was performed by using a Bruker microTOF-Q (ESI)
spectrometer. Crystal structures were obtained from either a Rigaku
Oxford Diffraction Xcalibur (Mo Kα (λ = 0.71073 Å)) or Supernova
(Cu Kα (λ = 1.54184 Å)) diffractometer. FTIR-ATR analyses were
performed on a PerkinElmer Spectrum100. Solution analyses of air
sensitive samples were performed by using a Mettler Toledo ReactIR
and iC IR 7.0 with a Diamond DiComp probe. Elemental analyses were
performed by Elemental Microanalysis Ltd.
General Procedure for the Synthesis of 1,1-Diphosphinea-
mide Ligands (2). A Schlenk flask was charged with KHMDS (300
mg, 1.5 mmol) before adding MeCN (3 mL). To this suspension
HPPh2 (1.04 mL, 6 mmol) was added with stirring. A solution of the
propynamide (3 mmol) in MeCN (4 mL) was added dropwise over 10
min, and the solution was stirred for 16 h. The reaction was quenched
by addition of MeOH. Solvent was removed in vacuo, yielding the crude
product. The crude product was mounted on alumina and purified by
filtration under an inert atmosphere (5% CH2Cl2/hexane (removes
most HPPh2), 50% CH2Cl2/hexane).
Synthesis of 2a. Ligand 2a was synthesized by using the general
procedure with N-phenyl-2-propynamide (72.6 mg, 0.5 mmol). The
product was isolated as a white solid in 62% yield (161 mg, 0.31 mmol).
Data correspond to previous literature. 1H NMR (500 MHz, CDCl3): δ
7.64−7.63 (m, 4H, P(PhH)2), 7.52−7.50 (m, 4H, P(PhH)2), 7.32−
7.27 (m, 7H, P(PhH)2), 7.25−7.18 (m, 7H, P(PhH)2/NPhH), 7.10 (d,
J = 8.0, 2H, N-o-PhH), 7.01 (t, J = 7.4, 1H, N-p-PhH), 6.15 (br s, 1H,
NH), 4.16 (t, J = 5.7, 1H, CH(PPh2)2), 2.37 (td, J = 9.2, J = 5.7, 2H,
CH2CH(PPh2)2). 13C{1H} NMR (126 MHz, CDCl3): δ 169.4 (CO),
137.6 (N−Ph), 136.2 (app t, J = 4.3, PPh), 136.0 (app t, J = 3.2, PPh),
134.8 (app t, J = 11.0, PPhH), 133.7 (app t, J = 10.3, PPhH), 129.4
(PPhH) 128.9 (NPhH), 128.7 (PPhH), 128.5 (app t, J = 3.6, PPhH),
128.3 (app t, J = 3.9, PPhH), 124.1 (NPhH), 119.7 (NPhH), 37.8 (t, J =
8.6, CH2CH(PPh2)2), 27.2 (t, J = 22.9, CH(PPh2)2). 31P{1H} NMR
(202 MHz, CDCl3): δ −6.6. FTIR-ATR: ν (cm−1): 3319 (N−H), 1678
(CO). HRMS (API): calcd for C33H30NOP2+ [M + H]+: 518.1802;
found: 518.1805.
Synthesis of 2b. Ligand 2b was synthesized by using the general
procedure with N-dimethylphenylpropynamide (520 mg, 3 mmol).
The product was isolated as a white powder in 66% yield (1.08 g, 1.98
1
mmol). H NMR (500 MHz, C6D6): δ 7.84−7.78 (m, 4H, PPh2),
7.73−7.67 (m, 4H, PPh2), 7.08−6.95 (m, 12H, PPh2), 6.94 (app dd, J =
8.5, J = 6.3, 1H, p-ArH), 6.89 (d, J = 7.4, 2H, m-ArH), 5.08 (s, 1H, NH),
4.63 (t, J = 5.0, 1H, CH(PPh2)2), 2.49 (td, J = 9.9, J = 5.0, 2H,
CH2CH(PPh2)2), 1.83 (s, 6H, ArCH3). 13C{1H) NMR (126 MHz,
C6D6): δ 168.9 (t, J = 2.9, CO), 137.6 (app q, J = 5.6, PPh2), 135.8 (s, o-
ArMe), 135.0 (app t, J = 11.2, PPh2H), 134.9 (i-Ar), 134.3 (app t, J =
10.7, PPh2H), 129.1 (PPh2H), 129.0 (PPh2H), 128.7 (app t, J = 3.6,
PPh2H), 128.5 (app t, J = 3.7, PPh2H), 128.1 (s, m-ArH), 127.1 (s, p-
ArH), 36.0 (t, J = 10.1, CH2CH(PPh2)2), 26.1 (t, J = 24.5,
CH2CH(PPh2)2), 18.7 (s, ArMe). 31P{1H} NMR (202 MHz, C6D6):
δ −3.6; mp (°C) 143−146. HRMS (ESI−): calcd for C35H32NOP2− [M
− H]− 544.2037; found: 544.1972.
Synthesis of 2c. Ligand 2c was synthesized by using the general
procedure with N-diisopropylphenylpropynamide (520 mg, 3 mmol).
The product was isolated as a white powder in 68% yield (1.23 g, 2.05
mmol). 1H and 31P{1H} NMR show there are rotamers in solution (5:1,
2c:2c′). 1H NMR (500 MHz, CDCl3): 2c, δ 7.54−7.50 (m, 4H, PPh2),
7.43−7.40 (m, 4H, PPh2), 7.26−7.08 (m, 13H, p-ArH/PPh2), 7.01 (d, J
= 7.8, 2H, m-ArH), 6.04 (s, 1H, NH), 4.09 (t, J = 5.1, 1H, CH(PPh2)2),
2.55 (td, J = 9.9, J = 5.1, 2H, CH2CH(PPh2)2), 2.49 (sept, J = 6.9, 2H,
CH), 0.96 (d, J = 6.9, 12H, CH3); 2c′, δ 7.34−7.31 (m, 4H, PPh2),
7.26−7.08 (m, 17H, p-ArH/PPh2), 6.95 (d, J = 7.8, 2H, m-ArH), 6.26
152
Organometallics 2021, 40, 148−155